SIRT1 and chronic kidney disease: This suggests that dysregulation of vascular SIRT1 and SIRT3 may contribute to an increased risk of atherothrombotic events in patients with chronic kidney disease, a predominant cause of mortality in this demographic (Rodriguez and Seta, 2021).